Changing the standard of care in the NICU for neonates with HIE

The only FDA approved device for the treatment of hypoxic-ischemic encephalopathy (HIE) in term infants, the Olympic Cool-Cap System is a unique and complete system utilizing a special cooling cap to provide selective brain cooling while maintaining core temperature at safe levels through the use of a radiant warmer.

Administered to newborns within the first six hours of life, treatment with the Olympic Cool-Cap System can prevent or significantly reduce the severity of neurologic injury associated with HIE.

Clinical benefits

Provides neuroprotection while minimizing the side-effects due to hypothermia
Allows neonatal brain cooling while maintaining patient's core temperature at safe levels
Results in meaningful improvements in neurodevelopmental outcome and survival rates at 18 months of age
Improved outcome for babies with early intervention
Better treatment through better diagnosis

The Olympic CFM 6000 cerebral function monitor helps assess the extent of HIE to determine if cooling is indicated
When used in conjunction with the Cool-Cap System, the CFM 6000 monitor provides greater confidence in managing & treating babies in the first few hours of life
Proven safe & effective

In a randomized-controlled, multi-center, international clinical trial, the Olympic Cool-Cap system was shown to reduce or prevent neurological damage associated with HIE in some infants1